DK1855677T3 - 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser - Google Patents
3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoserInfo
- Publication number
- DK1855677T3 DK1855677T3 DK06765238T DK06765238T DK1855677T3 DK 1855677 T3 DK1855677 T3 DK 1855677T3 DK 06765238 T DK06765238 T DK 06765238T DK 06765238 T DK06765238 T DK 06765238T DK 1855677 T3 DK1855677 T3 DK 1855677T3
- Authority
- DK
- Denmark
- Prior art keywords
- psychoses
- schizophrenia
- cis
- treatment
- dihydrotetrabenzene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0516167.4A GB0516167D0 (en) | 2005-08-06 | 2005-08-06 | Pharmaceutical compounds |
| GB0516790A GB0516790D0 (en) | 2005-08-16 | 2005-08-16 | Pharmaceutical compounds |
| PCT/GB2006/002936 WO2007017654A1 (en) | 2005-08-06 | 2006-08-04 | 3, hb cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1855677T3 true DK1855677T3 (da) | 2009-02-09 |
Family
ID=37400949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06765238T DK1855677T3 (da) | 2005-08-06 | 2006-08-04 | 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20110257220A1 (da) |
| EP (2) | EP2050451B1 (da) |
| JP (1) | JP2009504622A (da) |
| KR (1) | KR20080033500A (da) |
| AT (2) | ATE415968T1 (da) |
| AU (1) | AU2006277753B2 (da) |
| CA (1) | CA2620960A1 (da) |
| CY (1) | CY1108843T1 (da) |
| DE (1) | DE602006004009D1 (da) |
| DK (1) | DK1855677T3 (da) |
| ES (1) | ES2318771T3 (da) |
| HK (1) | HK1111083A1 (da) |
| HR (1) | HRP20090074T3 (da) |
| MX (1) | MX2008001549A (da) |
| NZ (1) | NZ566011A (da) |
| PL (1) | PL1855677T3 (da) |
| PT (1) | PT1855677E (da) |
| RS (1) | RS50807B (da) |
| RU (1) | RU2407743C2 (da) |
| SI (1) | SI1855677T1 (da) |
| WO (1) | WO2007017654A1 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2081929T3 (pl) | 2006-11-08 | 2013-06-28 | Neurocrine Biosciences Inc | Podstawione związki 3-izobutylo-9,10-dimetoksy-1,3,4,6,7,11b-heksahydro-2H-pirydo[2,1-a]izochinolin-2-olowe i ich wytwarzania |
| US7897768B2 (en) | 2007-06-08 | 2011-03-01 | General Electric Company | Method for making tetrabenazine compounds |
| US8053578B2 (en) | 2007-11-29 | 2011-11-08 | General Electric Company | Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes |
| GB0810857D0 (en) * | 2008-06-13 | 2008-07-23 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| GB2463283A (en) * | 2008-09-08 | 2010-03-10 | Cambridge Lab | 3,11b-cis-dihydrotetrabenazine for use in treating asthma |
| GB2463451A (en) * | 2008-09-08 | 2010-03-17 | Cambridge Lab | 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia |
| EP3351247A1 (en) | 2010-06-01 | 2018-07-25 | Auspex Pharmaceutical, Inc. | Benzoquinolone inhibitors of vmat2 |
| JP6010108B2 (ja) | 2011-04-01 | 2016-10-19 | スリーエム イノベイティブ プロパティズ カンパニー | トリアジン系紫外線吸収剤を含むフィルム |
| EA201691512A1 (ru) | 2014-01-27 | 2017-01-30 | Оспекс Фармасьютикалз, Инк. | Бензохинолиновые ингибиторы везикулярного переносчика моноамина 2 |
| KR102328058B1 (ko) | 2014-02-07 | 2021-11-17 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 항정신병 약물 및 ｖｍａｔ２ 억제제를 포함하는 제약 조성물 및 그의 용도 |
| CN108473489B (zh) | 2015-10-30 | 2022-09-02 | 纽罗克里生物科学有限公司 | Valbenazine盐及其多晶形物 |
| LT3394057T (lt) | 2015-12-23 | 2022-06-27 | Neurocrine Biosciences, Inc. | Sintezės būdas, skirtas pagaminti (s)-(2r,3r,11br)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1h-pirido[2,1-a]izochinolin-2-ilo 2-amino-3-metilbutanoato di(4-metilbenzensulfonatą) |
| JP2020500875A (ja) * | 2016-12-02 | 2020-01-16 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 統合失調症または統合失調感情障害を処置するためのバルベナジンの使用 |
| SG11201906883SA (en) | 2017-01-27 | 2019-08-27 | Neurocrine Biosciences Inc | Methods for the administration of certain vmat2 inhibitors |
| GB201705306D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705303D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705304D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705302D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| AU2018335259A1 (en) | 2017-09-21 | 2020-04-09 | Neurocrine Biosciences, Inc. | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| US10993941B2 (en) | 2017-10-10 | 2021-05-04 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| CA3077149A1 (en) | 2017-10-10 | 2019-04-18 | Neurocrine Biosciences, Inc. | Methods for the administration of (s)-2-amino-3-methyl-butyric acid (2r,3r,11br)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2yl ester and salts thereof |
| KR20210044817A (ko) | 2018-08-15 | 2021-04-23 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2830993A (en) | 1958-04-15 | Quinolizine derivatives | ||
| US2843591A (en) | 1958-07-15 | Method for preparing same | ||
| US6087376A (en) * | 1997-02-05 | 2000-07-11 | University Of Kentucky Research Foundation | Use of lobeline compounds in the treatment of central nervous system diseases and pathologies |
| GB2410947B (en) * | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
-
2006
- 2006-08-04 AT AT06765238T patent/ATE415968T1/de active
- 2006-08-04 JP JP2008525620A patent/JP2009504622A/ja not_active Ceased
- 2006-08-04 PL PL06765238T patent/PL1855677T3/pl unknown
- 2006-08-04 NZ NZ566011A patent/NZ566011A/en not_active IP Right Cessation
- 2006-08-04 SI SI200630210T patent/SI1855677T1/sl unknown
- 2006-08-04 US US11/997,591 patent/US20110257220A1/en not_active Abandoned
- 2006-08-04 CA CA002620960A patent/CA2620960A1/en not_active Abandoned
- 2006-08-04 PT PT06765238T patent/PT1855677E/pt unknown
- 2006-08-04 RS RSP-2009/0055A patent/RS50807B/sr unknown
- 2006-08-04 EP EP08170385A patent/EP2050451B1/en active Active
- 2006-08-04 KR KR1020087005308A patent/KR20080033500A/ko not_active Application Discontinuation
- 2006-08-04 RU RU2008108623/04A patent/RU2407743C2/ru not_active IP Right Cessation
- 2006-08-04 DE DE602006004009T patent/DE602006004009D1/de active Active
- 2006-08-04 DK DK06765238T patent/DK1855677T3/da active
- 2006-08-04 ES ES06765238T patent/ES2318771T3/es active Active
- 2006-08-04 WO PCT/GB2006/002936 patent/WO2007017654A1/en active Application Filing
- 2006-08-04 EP EP06765238A patent/EP1855677B1/en active Active
- 2006-08-04 AU AU2006277753A patent/AU2006277753B2/en not_active Expired - Fee Related
- 2006-08-04 MX MX2008001549A patent/MX2008001549A/es active IP Right Grant
- 2006-08-04 AT AT08170385T patent/ATE534391T1/de active
-
2008
- 2008-05-20 HK HK08105580.7A patent/HK1111083A1/xx not_active IP Right Cessation
-
2009
- 2009-02-06 HR HR20090074T patent/HRP20090074T3/xx unknown
- 2009-02-26 CY CY20091100221T patent/CY1108843T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE415968T1 (de) | 2008-12-15 |
| DE602006004009D1 (de) | 2009-01-15 |
| RU2008108623A (ru) | 2009-09-20 |
| EP2050451B1 (en) | 2011-11-23 |
| PL1855677T3 (pl) | 2009-07-31 |
| NZ566011A (en) | 2011-01-28 |
| SI1855677T1 (sl) | 2009-04-30 |
| EP1855677B1 (en) | 2008-12-03 |
| ES2318771T3 (es) | 2009-05-01 |
| EP2050451A1 (en) | 2009-04-22 |
| HRP20090074T3 (en) | 2009-04-30 |
| MX2008001549A (es) | 2008-04-04 |
| PT1855677E (pt) | 2009-01-13 |
| US20110257220A1 (en) | 2011-10-20 |
| RS50807B (sr) | 2010-08-31 |
| WO2007017654A1 (en) | 2007-02-15 |
| AU2006277753A1 (en) | 2007-02-15 |
| KR20080033500A (ko) | 2008-04-16 |
| CA2620960A1 (en) | 2007-02-15 |
| HK1111083A1 (en) | 2008-08-01 |
| JP2009504622A (ja) | 2009-02-05 |
| AU2006277753B2 (en) | 2011-11-10 |
| EP1855677A1 (en) | 2007-11-21 |
| ATE534391T1 (de) | 2011-12-15 |
| RU2407743C2 (ru) | 2010-12-27 |
| CY1108843T1 (el) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1855677T3 (da) | 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser | |
| FIC20210022I1 (fi) | tukatinibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossa | |
| NO20070468L (no) | Sammensetninger og fremgangsmater for behandling av dyslipidemi | |
| DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
| HK1111084A1 (en) | 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
| NO20091955L (no) | Antivirale sammensetninger, og fremgangsmater for anvendelse | |
| SE0203825D0 (sv) | Novel fused heterocycles and uses thereof | |
| DK1881830T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet | |
| ATE511512T1 (de) | Olanzapinpamoat-dihydrat | |
| PT2366393E (pt) | Roflumilaste para o tratamento da hipertensão pulmonar | |
| TN2012000111A1 (en) | Compounds useful against kinetoplastideae parasites | |
| ATE411310T1 (de) | Reinigungsverfahren von moxonidine | |
| DK1523985T3 (da) | Ikke-radioaktivt strontiumholdigt middel til behandling af kræft | |
| CY1111067T1 (el) | Χρηση της ν-(διβενζ (β,f) οξεπιν-10-υλμεθυλ) -ν-μεθυλ-ν-προπ-2-υνυλαμινης (omigapil) στην προληψη και/ή την θεραπεια της μυϊκης δυστροφiας | |
| GB0513835D0 (en) | HIV inhibitors | |
| DK1951718T3 (da) | 4-Oxadiazolyl-piperidinforbindelser og anvendelse deraf |